Healthcare ❯Pharmaceuticals ❯Drug Development ❯Clinical Trials

Side Effects

New Schizophrenia Drug Cobenfy Shows Mixed Results in Trials

Biogen Discontinues Controversial Alzheimer's Drug Aduhelm